You have 9 free searches left this month | for more free features.

atezolizumab

Showing 1 - 25 of 295

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Endometrial Cancer, Metastasis Trial (Atezolizumab, ONC201)

Not yet recruiting
  • Endometrial Cancer
  • Metastasis
  • (no location specified)
Sep 12, 2022

Hepatocellular Carcinoma Trial (NP137, Atezolizumab, Bevacizumab)

Not yet recruiting
  • Hepatocellular Carcinoma
  • (no location specified)
Sep 23, 2022

Hepatocellular Carcinoma Trial (Ezurpimtrostat, Atezolizumab, Bevacizumab)

Not yet recruiting
  • Hepatocellular Carcinoma
  • (no location specified)
Jul 4, 2022

Stage II Melanoma Trial in United States (Atezolizumab, Tiragolumab, Signatera Assay)

Not yet recruiting
  • Stage II Melanoma
  • Atezolizumab
  • +2 more
  • Duarte, California
  • +5 more
Jun 6, 2022

Idiopathic Pulmonary Fibrosis Trial in Los Angeles (Atezolizumab)

Not yet recruiting
  • Idiopathic Pulmonary Fibrosis
  • Atezolizumab
  • Los Angeles, California
    Cedars-Sinai Medical Center
Aug 23, 2022

Cutaneous Melanoma Trial in Houston (Atezolizumab)

Recruiting
  • Cutaneous Melanoma
  • Atezolizumab
  • Houston, Texas
    Houston Methodist Hospital
Dec 28, 2021

Breast Cancer Trial in Boston (Atezolizumab, Stereotactic radiosurgery (SRS))

Active, not recruiting
  • Breast Cancer
  • Atezolizumab
  • Stereotactic radiosurgery (SRS)
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
Aug 15, 2022

Breast Cancer Trial (Letrozole, Atezolizumab)

Withdrawn
  • Breast Cancer
  • (no location specified)
Jun 10, 2022

Intrahepatic Cholangiocarcinoma Trial in Bad Saarow (Atezolizumab, Derazantinib)

Recruiting
  • Intrahepatic Cholangiocarcinoma
  • Bad Saarow, Germany
    HELIOS KLinikum Bad Saarow
Jun 2, 2022

Hepatocellular Carcinoma, Resectable Hepatocellular Carcinoma Trial in Boston (Atezolizumab, Bevacizumab, Stereotactic Beam

Recruiting
  • Hepatocellular Carcinoma
  • Resectable Hepatocellular Carcinoma
  • Atezolizumab
  • +2 more
  • Boston, Massachusetts
    Massachusetts General Hospital Cancer Center
Feb 10, 2022

Colorectal Cancer Trial in Omaha (XL092, Atezolizumab, Regorafenib)

Recruiting
  • Colorectal Cancer
  • Omaha, Nebraska
    Exelixis Clinical Site #1
Jul 26, 2022

Hepatocellular Carcinoma Trial in Tampa (Selinexor Pill, Bevacizumab, Atezolizumab)

Recruiting
  • Hepatocellular Carcinoma
  • Selinexor Pill
  • +2 more
  • Tampa, Florida
    Moffitt Cancer Center
Aug 16, 2022

Solid Tumor Trial in Dallas (Atezolizumab, Vincristine, Irinotecan)

Not yet recruiting
  • Solid Tumor
  • Atezolizumab
  • +3 more
  • Dallas, Texas
    The University of Texas Southwestern Medical Center
Mar 29, 2022

Locally Advanced Cervical Cancer Trial in Villejuif (Atezolizumab, Radiotherapy, Cisplatin)

Recruiting
  • Locally Advanced Cervical Cancer
  • Atezolizumab
  • +2 more
  • Villejuif, Val De Marne, France
    Gustave Roussy
Feb 15, 2022

Cholangiocarcinoma, Liver Cancer Trial in Houston (Infigratinib, Atezolizumab, Bevacizumab)

Not yet recruiting
  • Cholangiocarcinoma
  • Liver Cancer
  • Houston, Texas
    M D Anderson Cancer Center
Aug 18, 2022

Non Small Cell Lung Cancer Trial in Changsha (Atezolizumab)

Not yet recruiting
  • Non Small Cell Lung Cancer
  • Atezolizumab
  • Changsha, Hunan, China
    Hunan Cancer hospital
May 19, 2022

HER2-positive Metastatic Breast Cancer, CNS Metastases Trial in Chicago, Boston (ATEZOLIZUMAB, PERTUZUMAB, TRASTUZUMAB)

Active, not recruiting
  • HER2-positive Metastatic Breast Cancer
  • Central Nervous System Metastases
  • ATEZOLIZUMAB
  • +2 more
  • Chicago, Illinois
  • +1 more
Mar 14, 2022

Squamous Cell Carcinoma of Head and Neck Trial in Essen (Atezolizumab)

Recruiting
  • Squamous Cell Carcinoma of Head and Neck
  • Atezolizumab
  • Essen, Germany
    University Hospital Essen
Oct 6, 2021

Prostate Cancer, Metastatic Castration-resistant Prostate Cancer Trial in Boston (Abemaciclib, Atezolizumab)

Recruiting
  • Prostate Cancer
  • Metastatic Castration-resistant Prostate Cancer
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Sep 20, 2021

Refractory Solid Tumor, Hepatocellular Carcinoma, Malignant Solid Tumor Trial in Memphis (Atezolizumab, Sorafenib, Bevacizumab)

Recruiting
  • Refractory Solid Tumor
  • +4 more
  • Atezolizumab
  • +3 more
  • Memphis, Tennessee
    St. Jude Children's Research Hospital
Aug 4, 2022

Triple Negative Breast Cancer Trial in London (Atezolizumab, Ipatasertib, Paclitaxel)

Active, not recruiting
  • Triple Negative Breast Cancer
  • Atezolizumab
  • +4 more
  • London, United Kingdom
    Barts Health NHS Trust
Aug 10, 2022

Urothelial/Bladder Cancer, Nos Trial in New York (Atezolizumab, PGV001, Poly ICLC)

Completed
  • Urothelial/Bladder Cancer, Nos
  • Atezolizumab
  • +3 more
  • New York, New York
    Icahn School of Medicine at Mount Sinai
Mar 7, 2022

Small Cell Lung Cancer Recurrent Trial in Goyang-si (Atezolizumab)

Recruiting
  • Small Cell Lung Cancer Recurrent
  • Atezolizumab
  • Goyang-si, Gyeonggi-do, Korea, Republic of
    National Cancer Center
Apr 4, 2022

Colorectal Cancer Metastatic Trial in Phoenix, Jacksonville, Rochester (PolyPEPI1018, Atezolizumab)

Recruiting
  • Colorectal Cancer Metastatic
  • Phoenix, Arizona
  • +2 more
Jun 28, 2022

Cutaneous Squamous Cell Carcinoma Trial in Stanford (Atezolizumab)

Recruiting
  • Cutaneous Squamous Cell Carcinoma
  • Atezolizumab
  • Stanford, California
    Stanford University
Jun 30, 2021